Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
Clinical trial NCT02405585 · TERMINATED
Trial details
- NCT number
- NCT02405585
- Sponsor
- NewLink Genetics Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.